Revolutionary Gene Therapy for Sickle Cell Disease Approved by NHS
31 Jan 2025
In a remarkable medical breakthrough, the NHS has approved the use of a revolutionary £1.65 million gene therapy called exagamglogene autotemcel (exa-cel) for the treatment of sickle cell disease. This one-time gene therapy, which has the potential to offer a "functional cure" to patients, has raised hopes for those living...
Read More